[en] Brain-derived neurotrophic factor (BDNF) is one of the key signaling molecules that supports the viability of neural cells in various brain pathologies, and can be considered a potential therapeutic agent. However, several methodological difficulties, such as overcoming the blood⁻brain barrier and the short half-life period, challenge the potential use of BDNF in clinical practice. Gene therapy could overcome these limitations. Investigating the influence of viral vectors on the neural network level is of particular interest because viral overexpression affects different aspects of cell metabolism and interactions between neurons. The present work aimed to investigate the influence of the adeno-associated virus (AAV)-Syn-BDNF-EGFP virus construct on neural network activity parameters in an acute hypobaric hypoxia model in vitro. MATERIALS AND METHODS: An adeno-associated virus vector carrying the BDNF gene was constructed using the following plasmids: AAV-Syn-EGFP, pDP5, DJvector, and pHelper. The developed virus vector was then tested on primary hippocampal cultures obtained from C57BL/6 mouse embryos (E18). Acute hypobaric hypoxia was induced on day 21 in vitro. Spontaneous bioelectrical and calcium activity of neural networks in primary cultures and viability tests were analysed during normoxia and during the posthypoxic period. RESULTS: BDNF overexpression by AAV-Syn-BDNF-EGFP does not affect cell viability or the main parameters of spontaneous bioelectrical activity in normoxia. Application of the developed virus construct partially eliminates the negative hypoxic consequences by preserving cell viability and maintaining spontaneous bioelectrical activity in the cultures. Moreover, the internal functional structure, including the activation pattern of network bursts, the number of hubs, and the number of connections within network elements, is also partially preserved. BDNF overexpression prevents a decrease in the number of cells exhibiting calcium activity and maintains the frequency of calcium oscillations. CONCLUSION: This study revealed the pronounced antihypoxic and neuroprotective effects of AAV-Syn-BDNF-EGFP virus transduction in an acute normobaric hypoxia model.
Mitroshina, Еlena V; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23 ; Privolzhskiy Research Medical University, 10/1 Minin and Pozharsky Square, 603005
Mishchenko, Tatiana A; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23 ; Privolzhskiy Research Medical University, 10/1 Minin and Pozharsky Square, 603005
Usenko, Alexandra V; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Epifanova, Ekaterina ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Yarkov, Roman S; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Gavrish, Maria S; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Babaev, Alexey A; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Vedunova, Maria V; Lobachevsky State University of Nizhni Novgorod, Institute of Neuroscience, 23
Language :
English
Title :
AAV-Syn-BDNF-EGFP Virus Construct Exerts Neuroprotective Action on the Hippocampal Neural Network during Hypoxia In Vitro.
Publication date :
05 August 2018
Journal title :
International Journal of Molecular Sciences
ISSN :
1661-6596
eISSN :
1422-0067
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Ch
Neumann, T.J.; Thompson, J.W.; Raval, A.P.; Cohan, C.H.; Koronowski, K.B.; Perez-Pinzon, M.A. Increased BDNF protein expression after ischemic or PKC epsilon preconditioning promotes electrophysiologic changes that lead to neuroprotection. J. Cereb. Blood Flow Metab. 2015, 35, 121–130. [CrossRef] [PubMed]
Da Silva Meirelles, L.; Simon, D.; Regner, A. Neurotrauma: The Crosstalk between Neurotrophins and Inflammation in the Acutely Injured Brain. Int. J. Mol. Sci. 2017, 18, 1082. [CrossRef] [PubMed]
Ramos-Cejudo, J.; Gutiérrez-Fernández, M.; Otero-Ortega, L.; Rodríguez-Frutos, B.; Fuentes, B.; Vallejo-Cremades, M.T.; Hernanz, T.N.; Cerdán, S.; Díez-Tejedor, E. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke 2015, 46, 221–228. [CrossRef] [PubMed]
Schäbitz, W.R.; Schwab, S.; Spranger, M.; Hacke, W. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 1997, 17, 500–506. [CrossRef] [PubMed]
Ploughman, M.; Windle, V.; MacLellan, C.L.; White, N.; Doré, J.J.; Corbett, D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009, 40, 1490–1495. [CrossRef] [PubMed]
Zhang, X.; Zhou, Y.; Li, H.; Wang, R.; Yang, D.; Li, B.; Fu, J. Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia. Int. J. Mol. Med. 2018, 41, 3185–3194. [CrossRef] [PubMed]
Schäbitz, W.R.; Berger, C.; Kollmar, R.; Seitz, M.; Tanay, E.; Kiessling, M.; Schwab, S.; Sommer, C. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 2004, 35, 992–997. [CrossRef] [PubMed]
Berretta, A.; Tzeng, Y.C.; Clarkson, A.N. Post-stroke recovery: The role of activity-dependent release of brain-derived neurotrophic factor. Expert Rev. Neurother. 2014, 14, 1335–1344. [CrossRef] [PubMed]
Zhu, J.M.; Zhao, Y.Y.; Chen, S.D.; Zhang, W.H.; Lou, L.; Jin, X. Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia. J. Int. Med. Res. 2011, 39, 488–498. [CrossRef] [PubMed]
Phillips, H.S.; Hains, J.M.; Armanini, M.; Laramee, G.R.; Johnson, S.A.; Winslow, J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 1991, 7, 695–702. [CrossRef]
Peng, S.; Wuu, J.; Mufson, E.J.; Fahnestock, M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. J. Neurochem. 2005, 93, 1412–1421. [CrossRef] [PubMed]
Iulita, M.F.; Millón, M.B.; Pentz, R.; Aguilar, L.F.; Do Carmo, S.; Allard, S.; Michalski, B.; Wilson, E.N.; Ducatenzeiler, A.; Bruno, M.A.; et al. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer’s disease. Neurobiol. Dis. 2017, 108, 307–323. [CrossRef] [PubMed]
Arancibia, S.; Silhol, M.; Moulière, F.; Meffre, J.; Höllinger, I.; Maurice, T.; Tapia-Arancibia, L. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 2008, 31, 316–326. [CrossRef] [PubMed]
Song, J.H.; Yu, J.T.; Tan, L. Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy. Mol. Neurobiol. 2015, 52, 1477–1493. [CrossRef] [PubMed]
Criscuolo, C.; Fabiani, C.; Bonadonna, C.; Origlia, N.; Domenici, L. BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation. Neurobiol. Aging 2015, 36, 1303–1309. [CrossRef] [PubMed]
Tome, D.; Fonseca, C.P.; Campos, F.L.; Baltazar, G. Role of Neurotrophic Factors in Parkinson’s Disease. Curr. Pharm. Des. 2017, 23, 809–838. [CrossRef] [PubMed]
Nam, J.H.; Leem, E.; Jeon, M.T.; Jeong, K.H.; Park, J.W.; Jung, U.J.; Kholodilov, N.; Burke, R.E.; Jin, B.K.; Kim, S.R. Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: Neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson’s disease. Mol. Neurobiol. 2015, 51, 487–499. [CrossRef] [PubMed]
Douglas-Escobar, M.; Rossignol, C.; Steindler, D.; Zheng, T.; Weiss, M.D. Neurotrophin-induced migration and neuronal differentiation of multipotent astrocytic stem cells in vitro. PLoS ONE 2012, 7, e51706. [CrossRef] [PubMed]
Rose, C.R.; Blum, R.; Kafitz, K.W.; Kovalchuk, Y.; Konnerth, A. From modulator to mediator: Rapid effects of BDNF on ion channels. Bioessays 2004, 26, 1185–1194. [CrossRef] [PubMed]
Martin, J.L.; Finsterwald, C. Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development. Commun. Integr. Biol. 2011, 4, 14–16. [CrossRef] [PubMed]
Kowiański, P.; Lietzau, G.; Czuba, E.; Waśkow, M.; Steliga, A.; Moryś, J. BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity. Cell. Mol. Neurobiol. 2018, 38, 579–593. [CrossRef] [PubMed]
Grade, S.; Weng, Y.C.; Snapyan, M.; Kriz, J.; Malva, J.O.; Saghatelyan, A. Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum. PLoS ONE 2013, 8, e55039. [CrossRef] [PubMed]
Cook, D.J.; Nguyen, C.; Chun, H.N.; Llorente, I.; Chiu, A.S.; Machnicki, M.; Zarembinski, T.I. Carmichael ST. Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke. J. Cereb. Blood Flow Metab. 2017, 37, 1030–1045. [CrossRef] [PubMed]
Destot-Wong, K.D.; Liang, K.; Gupta, S.K.; Favrais, G.; Schwendimann, L.; Pansiot, J.; Baud, O.; Spedding, M.; Lelièvre, V.; Mani, S.; et al. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Neuropharmacology 2009, 57, 277–286. [CrossRef] [PubMed]
Parnpiansil, P.; Jutapakdeegul, N.; Chentanez, T.; Kotchabhakdi, N. Exercise during pregnancy increases hippocampal brain-derived neurotrophic factor mRNA expression and spatial learning in neonatal rat pup. Neurosci. Lett. 2003, 352, 45–48. [CrossRef] [PubMed]
Ahn, S.Y.; Chang, Y.S.; Sung, D.K.; Sung, S.I.; Ahn, J.Y.; Park, W.S. Pivotal Role of Brain-Derived Neurotrophic Factor Secreted by Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage in Newborn Rats. Cell Transplant. 2017, 26, 145–156. [CrossRef] [PubMed]
Angelova, A.; Angelov, B.; Drechsler, M.; Lesieur, S. Neurotrophin delivery using nanotechnology. Drug Discov. Today 2013, 18, 1263–1271. [CrossRef] [PubMed]
Angelov, B.; Angelova, A.; Filippov, S.K.; Drechsler, M.; Štěpánek, P.; Lesieur, S. Multicompartment lipid cubic nanoparticles with high protein upload: Millisecond dynamics of formation. ACS Nano 2014, 8, 5216–5226. [CrossRef] [PubMed]
Angelova, A.; Angelov, B. Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair. Neural Regen. Res. 2017, 12, 886–889. [CrossRef] [PubMed]
Géral, C.; Angelova, A.; Lesieur, S. From molecular to nanotechnology strategies for delivery of neurotrophins: Emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics 2013, 5, 127–167. [CrossRef] [PubMed]
LeVaillant, C.J.; Sharma, A.; Muhling, J.; Wheeler, L.P.; Cozens, G.S.; Hellström, M.; Rodger, J.; Harvey, A.R. Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF. Mol. Ther. Methods Clin. Dev. 2016, 3, 16078. [CrossRef] [PubMed]
Yu, S.J.; Tseng, K.Y.; Shen, H.; Harvey, B.K.; Airavaara, M.; Wang, Y. Local administration of AAV-BDNF to subventricular zone induces functional recovery in stroke rats. PLoS ONE 2013, 8, e81750. [CrossRef] [PubMed]
Katsu-Jiménez, Y.; Loría, F.; Corona, J.C.; Díaz-Nido, J. Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency. Mol. Ther. 2016, 24, 877–889. [CrossRef] [PubMed]
Liu, S.; Sandner, B.; Schackel, T.; Nicholson, L.; Chtarto, A.; Tenenbaum, L.; Puttagunta, R.; Müller, R.; Weidner, N.; Blesch, A. Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury. Acta Biomater. 2017, 60, 167–180. [CrossRef] [PubMed]
Zhang, J.; Yu, Z.; Yu, Z.; Yang, Z.; Zhao, H.; Liu, L.; Zhao, J. rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int. J. Clin. Exp. Pathol. 2011, 4, 496–504. [PubMed]
Mishchenko, T.A.; Vedunova, M.V.; Mitroshina, E.V.; Pimashkin, A.S.; Mukhina, I.V. Neurotropic Effect of Brain-Derived Neurotrophic Factor at Different Stages of Dissociated Hippocampal Cultures Development in vitro. Sovremennye Tehnologii v Medicine 2015, 7, 47–54. [CrossRef]
Mukhina, I.V.; Kazantsev, V.B.; Khaspeckov, L.G.; Zakharov, Y.N.; Vedunova, M.V.; Mitroshina, E.V.; Korotchenko, S.A.; Koryagina, E.A. Multielectrode matrices—New possibilities in investigation of the neuronal network plasticity. Sovremennye Tehnol. Medicine 2009, 1, 8–15.
Zhong, J.B.; Li, X.; Zhong, S.M.; Liu, J.D.; Chen, C.B.; Wu, X.Y. Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway. Neuroreport 2017, 28, 910–916. [CrossRef] [PubMed]
Shirokova, O.M.; Frumkina, L.E.; Vedunova, M.V.; Mitroshina, E.V.; Zakharov, Y.N.; Khaspekov, L.G.; Mukhina, I.V. Morphofunctional Patterns of Neuronal Network Developing in Dissociated Hippocampal Cell Cultures. Sovremennye Tehnologii v Medicine 2013, 5, 6–13.
Chen, A.; Xiong, L.-J.; Tong, Y.; Mao, M. The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed. Rep. 2013, 1, 167–176. [CrossRef] [PubMed]
Sun, X.; Zhou, H.; Luo, X.; Li, S.; Yu, D.; Hua, J.; Mu, D.; Mao, M. Neuroprotection of brain-derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Int. J. Dev. Neurosci. 2008, 26, 363–370. [CrossRef] [PubMed]
Liu, Z.; Ma, D.; Feng, G.; Ma, Y.; Hu, H. Recombinant AAV-mediated expression of human BDNF protects neurons against cell apoptosis in Abeta-induced neuronal damage model. J. Huazhong Univ. Sci. Technol. Sci. 2007, 27, 233–236. [CrossRef] [PubMed]
Nakajima, H.; Uchida, K.; Yayama, T.; Kobayashi, S.; Guerrero, A.R.; Furukawa, S.; Baba, H. Targeted retrograde gene delivery of brain-derived neurotrophic factor suppresses apoptosis of neurons and oligodendroglia after spinal cord injury in rats. Spine 2010, 35, 497–504. [CrossRef] [PubMed]
Shi, Q.; Zhang, P.; Zhang, J.; Chen, X.; Lu, H.; Tian, Y.; Parker, T.L.; Liu, Y. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett. 2009, 465, 220–225. [CrossRef] [PubMed]
Tao, J.; Ji, F.; Liu, B.; Wang, F.; Dong, F.; Zhu, Y. Improvement of deficits by transplantation of lentiviral vector-modified human amniotic mesenchymal cells after cerebral ischemia in rats. Brain Res. 2012, 1448, 1–10. [CrossRef] [PubMed]
Yuste, R. From the neuron doctrine to neural networks. Nat. Rev. Neurosc. 2015, 16, 487–497. [CrossRef] [PubMed]
Tong, M.T.; Peace, S.T.; Cleland, T.A. Properties and mechanisms of olfactory learning and memory. Front. Behav. Neurosci. 2014, 8, 238. [CrossRef] [PubMed]
Guerzoni, L.P.; Nicolas, V.; Angelova, A. In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival. Pharm. Res. 2017, 34, 492–505. [CrossRef] [PubMed]
Angelov, B.; Angelova, A. Nanoscale clustering of the neurotrophin receptor TrkB revealed by super-resolution STED microscopy. Nanoscale 2017, 9, 9797–9804. [CrossRef] [PubMed]
Osborne, A.; Wang, A.X.; Tassoni, A.; Widdowson, P.S.; Martin, K.R. Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons. Hum. Gene Ther. 2018. [CrossRef] [PubMed]
Gao, M.; Lu, P.; Lynam, D.; Bednark, B.; Campana, W.M.; Sakamoto, J.; Tuszynski, M. BDNF gene delivery within and beyond templated agarose multi-channel guidance scaffolds enhances peripheral nerve regeneration. J. Neural Eng. 2016, 13, 066011. [CrossRef] [PubMed]
Ziemlińska, E.; Kügler, S.; Schachner, M.; Wewiór, I.; Czarkowska-Bauch, J.; Skup, M. Overexpression of BDNF increases excitability of the lumbar spinal network and leads to robust early locomotor recovery in completely spinalized rats. PLoS ONE 2014, 9, e88833. [CrossRef] [PubMed]
Ohira, K.; Kumanogoh, H.; Sahara, Y.; Homma, K.J.; Hirai, H.; Nakamura, S.; Hayashi, M. A truncated tropomyosin-related kinase B receptor, T1, regulates glial cell morphology via Rho GDP dissociation inhibitor 1. J. Neurosci. 2005, 25, 1343–1353. [CrossRef] [PubMed]
Ohira, K.; Funatsu, N.; Homma, K.J.; Sahara, Y.; Hayashi, M.; Kaneko, T.; Nakamura, S. Truncated TrkB-T1 regulates the morphology of neocortical layer I astrocytes in adult rat brain slices. Eur. J. Neurosci. 2007, 25, 406–416. [CrossRef] [PubMed]
Perea, G.; Navarrete, M.; Araque, A. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci. 2009, 32, 421–431. [CrossRef] [PubMed]
Bezzi, P.; Volterra, A. A neuron-glia signalling network in the active brain. Curr. Opin. Neurobiol. 2001, 11, 387–394. [CrossRef]
Hamilton, N.B.; Attwell, D. Do astrocytes really exocytose neurotransmitters? Nat. Rev. Neurosci. 2010, 11, 227–238. [CrossRef] [PubMed]
Zhang, F.; Zhong, R.; Qi, H.; Li, S.; Cheng, C.; Liu, X.; Liu, Y.; Le, W. Impacts of Acute Hypoxia on Alzheimer’s Disease-Like Pathologies in APPswe/PS1dE9 Mice and Their Wild Type Littermates. Front. Neurosci. 2018, 12, 314. [CrossRef] [PubMed]
Nucera, A.; Hachinski, V. Cerebrovascular and Alzheimer disease: Fellow travelers or partners in crime? J. Neurochem. 2018, 144, 513–516. [CrossRef] [PubMed]
Nielsen, R.B.; Egefjord, L.; Angleys, H.; Mouridsen, K.; Gejl, M.; Møller, A.; Brock, B.; Brændgaard, H.; Gottrup, H.; Rungby, J.; et al. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer’s disease. Alzheimer’s Dement. 2017, 13, 1143–1153. [CrossRef] [PubMed]
Herrera, M.I.; Udovin, L.D.; Toro-Urrego, N.; Kusnier, C.F.; Luaces, J.P.; Otero-Losada, M.; Capani, F. Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome. Front. Neurosci. 2018, 12, 339. [CrossRef] [PubMed]
Iwasaki, Y.; Negishim, T.; Inoue, M.; Tashiro, T.; Tabira, T.; Kimura, N. Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer’s disease. J. Neurosci. Res. 2012, 90, 981–989. [CrossRef] [PubMed]
Jiao, S.S.; Shen, L.L.; Zhu, C.; Bu, X.L.; Liu, Y.H.; Liu, C.H.; Yao, X.Q.; Zhang, L.L.; Zhou, H.D.; Walker, D.G.; et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease. Transl. Psychiatry 2016, 6, e907. [CrossRef] [PubMed]
Savolainen, M.; Emerich, D.; Kordower, J.H. Disease Modification through Trophic Factor Delivery. Methods Mol. Biol. 2018, 1780, 525–547. [CrossRef] [PubMed]
Tronci, E.; Napolitano, F.; Muñoz, A.; Fidalgo, C.; Rossi, F.; Björklund, A.; Usiello, A.; Carta, M. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Exp. Neurol. 2017, 297, 73–81. [CrossRef] [PubMed]
Zakharov, Y.N.; Mitroshina, E.V.; Shirokova, O.; Mukhina, I.V. Calcium transient imaging as tool for neuronal and glial network interaction study. Springer Proc. Math. Stat. Model. Algorithms Technol. Netw. Anal. 2013, 32, 225–232. [CrossRef]
